Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 1, 1997, Pages 163-171

  Moore, K ^a   Thomas, A ^a   Harding, K G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Interleukin 6; Iodine; Macrophage; Tumor necrosis factor ; Wound healing

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CADEXOMER IODINE; CYTOKINE; INTERLEUKIN 6; IODINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; LEG ULCER; MACROPHAGE; WOUND DRESSING; WOUND HEALING;

ANIMALS; BANDAGES; CELL LINE; CYTOKINES; HUMANS; IODINE; IODINE COMPOUNDS; LEG ULCER; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; WOUND HEALING; WOUND INFECTION;

BACTERIA (MICROORGANISMS);

EID: 0031028574     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00128-8     Document Type: Article

References (21)

1. Aderka D., Jumming L. and Vilcek J. (1989) IL-6 inhibits lipopolysaccharide-induced tumour necrosis factor production in cultured human monocytes, U937 cells and in mice. J. Immunol. 143, 3517-3523.
2. Barbul A., Breslin R. J., Woodyard J. P., Wasserkrug H. L. and Efron G. (1989) The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing. Ann. Surg. 209, 479-483.
3. Blistein-Willinger E. (1991) The role of growth factors in wound healing. Skin Pharmacol. 4, 175-182.
4. Brown R. L., Breeden M. P. and Greenhalgh D. G. (1994) PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J. Surg. Res. 56, 562-570.
5. Cromack D. T., Porras-Reyes B. and Mustoe T. A. (1990) Current concepts in wound healing: growth factor and macrophage interaction. J. Trauma 30, S129-133.
6. Clark R. A. and Klebanoff S. J. (1975) Neutrophil-mediated tumour cell cytotoxicity: role of the peroxidase system. J. Exp. Med. 141, 1442-1447.
7. Dyson M., Young S. R., Pendle C. L., Webster D. F. and Lang S. M. (1988) Comparison of the effects of moist and dry conditions on dermal repair. J. Invest. Dermat. 9, 435-439.
8. Galanoud P., Crevon M. C., Grenounou M., Agnercy J. and Dormont J. (1980) Sodium periodate-induced suppressor T cells of the human in vitro antibody response. Cell. Immunol. 51, 85-91.
9. Harcup J. W. and Saul P. A. (1986) A study of the effect of Cadexomer iodine in the treatment of venous ulcers. Br. J. Clin. Pract. 40, 360-364.
10. Groves R. W., Allen M. H., Ross E. L., Barker J. N. W. N. and MacDonald D. M. (1995) TNFα is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132, 345-352.
11. Heumann D., Barras C., Severin A., Glauser M. P. and Tomasz A. (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62, 2715-2721.
12. Kero M., Tarvainen K., Hollmen A. and Pekanmaki K. (1987) A comparison of Cadexomer iodine with dextranomer in the treatment of venous leg ulcers. Curr. Ther. Res. 42, 761-767.
13. Lukacs N. W., Strieter R. M., Elner V., Evanoff H. L., Burdick M. D. and Kunkel S. L. (1995) Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 86, 2767-2773.
14. Meager A., Parti S., Leung H. and Mahon B. (1987) Preparation and characterisation of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor. Hybridoma 6, 305-311.
15. Nathan C. F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-326.
16. Nathan C. F., Brukner L. H., Silverstein S. C. and Cohn Z. A. (1979) Extracellular cytolysis by activated macrophages and granulocytes 1. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med. 149, 84-99.
17. Ninneman J. L. and Stein M. D. (1981) Suppressor cell induction by Povidone iodine: in vitro demonstration of a consequence of clinical burn treatment with Betadine. J. Immunol. 126, 1905-1908.
18. Ormiston M. C., Seymour M. T., Venn G. E., Cohen R. I. and Fox J. A. (1985) Controlled trial of Iodosorb in chronic venous ulcers. Br. Med. J. 291, 308-310.
19. Rapala K., Laato M., Niinikoski J., Kujari H., Soder O., Mauviel A. and Pujol J. P. (1991) Tumor necrosis factor alpha inhibits wound healing in the rat. Eur. Surg. Res. 23, 261-268.
20. Schlenger K., Hockel M., Schwab R., Frischmann-Berger R. and Vaupel P. (1994) How to improve the uterotomy healing. Effects of fibrin and tumour necrosis factor-α in the rat uterotomy model. J. Surg. Res. 56, 235-241.
21. Skog E., Arnesjo B., Troeng T., Gjores J. E., Bergljung L., Gundersen J., Hallbrook T., Hessman Y., Hillstrom L., Mansson T., Eilard U., Ekloff B., Plate G. and Norgren L. (1983) A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br. J. Dermatol. 109, 77-83.